Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures
1 other identifier
interventional
50
1 country
1
Brief Summary
In England each year over 70,000 people fracture their hip. Most of these patients are elderly females with the fracture occurring after a simple trip or stumble. Approximately half of these fractures are classified from their relationship to the hip joint capsule as intracapsular. These fractures are subdivided into those that are displaced and those that are undisplaced. The majority of displaced fractures are treated with a replacement arthroplasty. Current treatment for the undisplaced fractures is generally by internal fixation of the fracture using screws and a plate, although some centres prefer replacement arthroplasty. A recent randomised study on patients from Norway with undisplaced intracapsular fractures treated with either internal fixation or arthroplasty has just reported reduced complications and re-operations for those patients treated with an arthroplasty. In addition functional results were marginally better for those patients treated with an arthroplasty. Current practice in the UK is generally to treat these fractures by internal fixation. This study aims to see if replacement arthroplasty can indeed lead to the advantages suggested from the Norwegian study. Patients who satisfy the inclusion criteria and are willing to participate will be randomised to receive either reduction and internal fixation of the fracture with a screw and plate device or alternatively replacement of their femoral head with an artificial hip replacement (hemiarthroplasty). After surgery patients will receive the same treatment as normal and be discharge home when able, with follow-up review in the hip fracture clinic. Subsequent follow-up for the research project is by phone calls from a research nurse who is blinded to the type of treatment that the patient has received. There will be no additional investigations or out-patient follow-up visits for these patients in comparison to normal treatment protocols. Results of the study will ultimately be published in a medical journal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 10, 2016
CompletedFirst Posted
Study publicly available on registry
December 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedDecember 19, 2016
December 1, 2016
3.3 years
June 10, 2016
December 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
regain of mobility using the Parker and Palmer mobility scale
Assessment is using the Parker and Palmer mobility score (Parker MJ, Palmer CR. A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br. 1993;75:797-8.)
one year
Study Arms (2)
Cemented hemiarthroplasty
ACTIVE COMPARATORTreatment of the fracture by a replacement arthroplasty with a cemented CPT hemiarthroplasty (manafactured by Zimmer company, Warsaw IN, USA) inserted via an anteriolateral approach to the hip
Internal fixation
ACTIVE COMPARATORInternal fixation of the fracture with a screw and plate device (Targon FN plate, Aesculap cooperation, Tuttingham, Germany)
Interventions
Internal fixation of the fracture with a Targon FN implant (BBraun Ltd, Germany)
Replacement of the femoral head with a cemented hemiarthroplasty
Eligibility Criteria
You may not qualify if:
- patients who decline to participate or in whom consent or assent is not available
- patients admitted when MJP is not available to supervise treatment
- patients with pathological fractures from Paget's disease of bone secondary's from tumour
- patients with delayed presentation who would be treated conservatively
- patients considered unfit for either surgical procedure
- younger patients, aged less than 80 years who are independently mobile and very active will be excluded at treated by internal fixation (the risk of fracture healing complication for this group is less, whilst there is an increased risk of long term complications after arthroplasty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peterborough and Stamford Hospital NHS Foundation Trust
Peterborough, Cambs, PE36DA, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- consultant orthopaedic surgeon
Study Record Dates
First Submitted
June 10, 2016
First Posted
December 19, 2016
Study Start
May 1, 2016
Primary Completion
September 1, 2019
Last Updated
December 19, 2016
Record last verified: 2016-12